Turf war in the pharma industry (India)

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
The swadeshi versus videshi battle has broken out afresh in the Rs 67,000-cr Indian drug market as mutinationals step up their efforts to enter the branded generic space to compete with domestic drug makers.

Next time you visit a chemist, just observe what happens. You will hand over the doctor?s prescription, often unreadable, to the chemist who reaches out to the shelf, takes out a few strips of tablets and capsules, packs them in a brown envelope and hands it over to you. It?s almost mechanical. How is it different from, say, buying biscuit? You, at the chemist?s store, are not king, unlike in a grocery store or a car shop. You are not empowered to choose or evaluate. Those decisions have been made by your doctor. Unknown to you, drug makers have fought hard behind the scenes to make the doctor write that prescription. He has written a particular brand of a medicine probably because he has been educated well by that brand?s salesman, or perhaps he has been won over by the company with freebies and inducements. This is how the Rs 67,000-crore Indian drug market works.

http://www.business-standard.com/india/news/turf-war-inpharma-industry/488722/
 
Status
Not open for further replies.
Back
Top